86301004: Posterior pituitary hormone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Pituitary hormone\Posterior pituitary hormone

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Pituitary hormone\Posterior pituitary hormone

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

143127018 Posterior pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

828537018 Posterior pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3416611000005119 hypofysebaglapshormon da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Posterior pituitary hormone	Is a	Hypothalamus- og hypofysehormon	false	Inferred relationship	Some
Posterior pituitary hormone	Is a	Pituitary hormone	true	Inferred relationship	Some
Posterior pituitary hormone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Posterior pituitary hormone (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing oxytocin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
lypressin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocinpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 10 microgram/actuation nasal spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 200 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
desmopressinacetat 100 µg/1 ml opløsning til intranasal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
desmopressinacetat 4 µg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing terlipressin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
terlipressin 1 mg pulver og solvens til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressin 20 IE/ml injektionsvæske, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing precisely ergometrine maleate 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
ergometrinmaleat 500 µg/1 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
ergometrinmaleat + oxytocin 500 µg/5 enheder/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
oxytocin 5 enheder/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
oxytocin 10 enheder/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing ergometrine and oxytocin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Antidiuretic hormone product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
ergometrinmaleat 200 µg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 1.5mg/mL spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
methylergometrinmaleat 0,2 mg/ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
desmopressinacetat 0,01 % opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
oxytocin 10 enheder infusionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin 20unt/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.1mg/mL solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.01% spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Methylergonovine maleate 0.2mg/cc	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
methylergometrinmaleat 20 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
urea 40-50 % injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing posterior pituitary hormone (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Posterior pituitary hormone	Inferred relationship	Some	1
Product containing methylergometrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
desmopressinacetatpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
methylergometrinmaleatpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressintannatpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing ergometrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressinpræparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing desmopressin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Lypressin preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Ergonovine maleate preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressin 20 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressin 20 enheder/ml injektionsvæske, opløsning, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressin 20 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
ergometrinmaleat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoproston 10 mg vagitorium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoproston 1 mg/ml koncentrat til infusionsvæske, ampul a 0,75 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml med diluent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 400 microgram/mL vaginal gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Mifepristone 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing dinoprostone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing dinoprostone in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone-containing product in vaginal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing dinoprostone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing mifepristone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 10mg insert	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocin	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Antidiuretic hormone	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Adverse reaction caused by posterior pituitary hormones (disorder)	Causative agent	True	Posterior pituitary hormone	Inferred relationship	Some	1
Adverse reaction to posterior pituitary hormone NOS	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Posterior pituitary hormone poisoning NOS	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Poisoning caused by posterior pituitary hormone (disorder)	Causative agent	True	Posterior pituitary hormone	Inferred relationship	Some	1
Lypressin adverse reaction	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Accidental vasopressin poisoning (disorder)	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Adverse reaction caused by antidiuretic hormone	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin adverse reaction (disorder)	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Terlipressin adverse reaction	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Poisoning by vasopressin	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Intentional vasopressin poisoning	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
forgiftning med vasopressin, uvist med hvilken hensigt	Causative agent	False	Posterior pituitary hormone	Inferred relationship	Some
Terlipressin acetate (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Lypressin (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Argipressin (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin tannate (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Terlipressin (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
143127018	Posterior pituitary hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
828537018	Posterior pituitary hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3416611000005119	hypofysebaglapshormon	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)